Log In
BCIQ
Print this Print this
 

CLP-1004

  Manage Alerts
Collapse Summary General Information
Company Sorbent Therapeutics Inc.
DescriptionNon-absorbed potassium binder
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHyperkalemia
Indication DetailsTreat hyperkalemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today